Novel Palladium(II) and Platinum(II) Complexes with a Fluoropiperazinyl Based Ligand Exhibiting High Cytotoxicity and Anticancer Activity In Vitro

被引：13

作者：

Abu-Safieh, Kayed A. ^{[1
]}

Abu-Surrah, Adnan S. ^{[2
]}

Tabba, Hani D. ^{[2
]}

AlMasri, Huda A. ^{[1
]}

Bawadi, Randa M. ^{[3
]}

Boudjelal, Fadila M. ^{[3
]}

Tahtamouni, Lubna H. ^{[4
]}

机构：

[1] Hashemite Univ, Dept Chem, POB 150459, Zarqa 13115, Jordan

[2] Qatar Univ, Coll Arts & Sci, Dept Chem & Earth Sci, POB 2713, Doha, Qatar

[3] Univ Jordan, Dept Physiol & Biochem, Amman 11942, Jordan

[4] Hashemite Univ, Dept Biol & Biotechnol, Zarqa 13115, Jordan

来源：

JOURNAL OF CHEMISTRY | 2016年 / 2016卷

关键词：

CHIRAL PALLADIUM(II); ANTITUMOR; DESIGN; AGENTS; ASSAYS;

D O I：

10.1155/2016/7508724

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

cis-Dichloro-palladium(II) and cis-dichloro-platinum(II) complexes (2, 4) of the general formula [M(N-N)Cl-2] (M=Pd(II) and Pt(II), N-N= 1,2-diamino-4-fluoro-5-(4-methyl-1-piperazinyl) benzene, (DFMPB)) and the dicationic palladium(II) complex [Pd(N-N)(CH3CN)(2)](BF4)(2) (3) have been prepared and characterized by elemental analysis, H-1-NMR-, mass spectroscopy, and IR spectroscopy. The cytotoxic effect of these complexes against MDA-231 and MCF-7 human breast cancer cell lines and K562 human leukemia cell line has been studied. The influence was dose dependent and varies with cell type. The palladium(II) complex (2) showed superior cytotoxic effect compared with the corresponding platinum(II) complex and the standard, cisplatin, when tested against all the above cell lines.

引用

页数：7

共 31 条

[1] Synthesis of new 2-ferrocenyl-5-fluoro-6-(4-substituted-1-piperazinyl)-1H-benzimidazoles of potential biological interest
Abdel-Jalil, RJ
Voelter, W
[J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 2005, 42 (01) : 67 - 71
[2] Synthesis and properties of some 2,3-disubstituted 6-fluoro-7-(4-methyl-1-piperazinyl)quinoxalines
Abdel-Jalil, RJ
Al-Qawasmeh, RA
Voelter, W
Heeg, P
El-Abadelah, MM
Sabri, SS
[J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 2000, 37 (05) : 1273 - 1275
[3] Abu-Surrah A.S., 2008, Cancer Therapy, V6, P1
[4] New palladium(II) complexes bearing pyrazole-based Schiff base ligands: Synthesis, characterization and cytotoxicity
Abu-Surrah, Adnan S.
Abu Safieh, Kayed A.
Ahmad, Iman M.
Abdalla, Maher Y.
Ayoub, Mikdad T.
Qaroush, Abdussalam K.
Abu-Mahtheieh, Ahmad M.
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) : 471 - 475
[5] Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin
Abu-Surrah, AS
Kettunen, M
[J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (11) : 1337 - 1357
[6] Chiral palladium(II) and platinum(II) complexes of diaminocyclohexane:: X-ray structures of (1R,2R)-(-)-1,2-diaminocyclohexane dihydrochloride and its corresponding oxalato platinum(II) complex
Abu-Surrah, AS
Al-Allaf, TAK
Klinga, M
Ahlgren, M
[J]. POLYHEDRON, 2003, 22 (12) : 1529 - 1534
[7] Synthesis, crystal structure and initial biological evaluation of the new enantiomerically pure chiral palladium(II) complex trans-bis {endo(1R)-1,7,7-trimethylbicyclo [2.2.1]-heptan-2-amino}palladium(II)dichloride
Abu-Surrah, AS
Al-Allaf, TAK
Rashan, LJ
Klinga, M
Leskelä, M
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (11) : 919 - 922
[8] Ultrahigh molecular weight alternating propene/ethene/carbon monoxide terpolymers with elastic properties
AbuSurrah, AS
Eckert, G
Pechhold, W
Wilke, W
Rieger, B
[J]. MACROMOLECULAR RAPID COMMUNICATIONS, 1996, 17 (08) : 559 - 565
[9] Al-Allaf T. A. K, 1997, U.K. Patent, Patent No. [2 304 712, 2304712]
[10] Synthesis and cytotoxic evaluation of the first trans-palladium(II) complex with naturally occurring alkaloid harmine
Al-Allaf, TAK
Rashan, LJ
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (10) : 817 - 820

← 1 2 3 4 →